Betaglue
2 known investors
BetaGlue Therapeutics develops targeted nuclear radiotherapeutics for solid tumours, combining biotechnology, nuclear science, and interventional oncology to deliver radiation inside the tumour. Its product, YntraDose, is a Yttrium-90 microsphere radiotherapy aimed at treating pancreatic cancer and other solid tumours.
BiotechHealthtechMedical Devices
Investors · 2
Frequently asked questions
- What does Betaglue do?
- BetaGlue Therapeutics develops targeted nuclear radiotherapeutics for solid tumours, combining biotechnology, nuclear science, and interventional oncology to deliver radiation inside the tumour. Its product, YntraDose, is a Yttrium-90 microsphere radiotherapy aimed at treating pancreatic cancer and other solid tumours.
- Who are Betaglue's investors?
- Betaglue's investors include LIFTT, Neva Sgr..